Close
Shopping Cart
Your Cart is Empty

"Helping Families One Life at a Time"

By proudly working with the Autism Fragile X Foundation

Nutraceutical Footnotes and References

Footnotes

Peer review under responsibility of King Saud University.

References

1. Adams J.B., Holloway C. Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. Journal of Alternative and Complementary Medicine. 2004;10(6):1033–1039.

2. Adams J.A., Baral M., Geis E., Mitchell J., Ingram J., Hensley A., Zappia I. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B – Behavioral results. BMC Clinical Pharmacology. 2009;9:17.

3. Adams J.B., Audhya T., McDonough-Means S., Rubin R.A., Quig D., Geis E., Gehn E., Loresto M., Mitchell J., Atwood S., Barnhouse S., Lee W. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatrics. 2011;11(111)

4. Aga M., Iwaki K., Ueda Y., Ushio S., Masaki N., Fukuda S., Kimoto T., Ikeda M., Kurimoto M. Preventive effect of Coriandrum sativum (Chinese parsley) on localized lead deposition in ICR mice. Journal of Ethnopharmacology. 2001;77(2–3):203–208.

5. Al-Ayadhi L.Y., Bacha A.G.B., Kotb M., El-Ansary A.K. A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics. Behavior and Brain Function. 2012;8(4)

6. Ali A., Waly M.I., Al-Farsi Y.M., Essa M.F., Al-Sharbati M.M., Deth R.C. Hyperhomocysteinemia among Omani autistic children: a case control study. Acta Buiochemica Polonica. 2011;58(4):547–551.

7. Alissa E.M., Ferns G.A. Functional foods and nutraceuticals in the primary prevention of cardiovascular diseases. Journal of Nutrition and Metabolism. 2012 Article ID 569486.

8. Al-Yadhi L.Y., Mostafa G.A. Low plasma progranulin levels in children with autism. Journal of Neuroinflammation. 2011;8(111)

9. Al-Yafee Y.A., Al-Ayadhi L.Y., Haq S.H., El-Ansary A.K. Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia. BMC Neurology. 2011;11:139–145.

10. American Psychiatric Association . American Psychiatric Association; Washington, DC: 2000. (American Psychiatric Association, Diagnostic and Statistical Manual-Text Revision (DSMIV-TR TM)).

11. Amminger G.P., Berger G.E., Schafer M.R., Klier C., Friedrich M.H., Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biological Psychiatry. 2007;61:551–553.

12. Bakare M.O., Munir K.M., Kinney D.K. Association of hypomelanotic skin disorders with autism: links to possible etiologic role of vitamin-D levels in autism? Hypothesis (Tor) 2011;9(1)

13. Bent S., Bertoglio K., Ashwood P., Bostrom A., Hendren R.L. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. Journal of Autism Disorders. 2011;41:545–554.

14. Bolte S., Poustka F. The relation between general cognitive level and adaptive behavior domains in individuals with autism with and without co-morbid mental retardation. Child Psychiatry and Human Development. 2002;33:165–172.

15. Brower V. Nutraceuticals: poised for a healthy slice of the healthcare market? National Biotechnology. 1998;16:728–731.

16. Brown M.J., Willis T., Omalu B., Leiker R. Deaths from hypocalcemia after administration of edetate disodium: 2003–2005. Pediatrics. 2006:118.

17. Brudnak M.A. Probiotics as an adjuvant to detoxification protocols. Medical Hypotheses. 2002;58(5):382–395.

18. Buie T., Campbell D.B., Fuchs G.J., Furuta G.T., Levy J., Vandewater J. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010;125(Suppl 1):S1–S18.

19. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S. A genetic variant that disrupts MET transcription is associated with autism. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(45):16834–16839.

20. Caspi A., Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nature Reviews in Neuroscience. 2006;7(7):583–590.

21. Castellani M.L., Conti C.M., Kempuraj D.J., Salini V., Vecchiet J., Tete S. Autism and immunity: revisited study. International Journal of Immunopathology and Pharmacology. 2009;22:15–19.

22. Center for Disease Control. New data on autism spectrum disorder.

23. Cornish E. A balanced approach towards healthy eating in autism. Journal of Human Nutrition and Diet. 1998;11(6):501–509.

24. Cornish E. Gluten and casein free diets in autism: a study of the effects on food choice and nutrition. Journal of Human Nutrition and Diet. 2002;15(4):261–269.

25. Cornish S., Mehl-Madrona The role of vitamins and minerals in psychiatry. Integrative Medicine Insights. 2008;3:33–42.

26. Curtis L.T., Petel K. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review. Journal of Alternative and Complementary Medicine. 2008;14(1):79–85.

27. Danfors T., von Knorring A.L., Hartvig P., Langstrom B., Moulder R., Stromberg B. Tetrahydrobiopterin in the treatment of children with autistic disorder: a double-blind placebo-controlled crossover study. Journal of Clinical Psychpharmacology. 2005;25(5):485–489.

28. Defeat Autism Now (DAN) Project . Autism Research Institute; San Diego, CA: 2002. (Conference Proceedings, Consensus Reports, Medical Assessment Protocols).

29. Dolske M.C., Spollen J., McKay S., Lancashire E., Tolbert L. A preliminary trial of ascorbic acid as a supplemental therapy for autism. Progress in Neuro-psychopharmacology, Biology and Psychiatry. 1993;17:765–774.

30. Douglas L.C., Sanders M.E. Probiotics and prebiotics in dietetics practice. Journal of American Dietitians Association. 2008;108:510–521.

31. Elder J.H., Shankar M., Shuster J., Theriaque D., Burns S., Sherrill L. The gluten-free, casein-free diet in autism: results of a preliminary double-blind clinical trial. Journal of Autism and Developmental Disorders. 2006;36:413–420.

32. Ellaway C., Williams K., Leonard H., Higgins G., Wilcken B., Chritodoulou J. Rett syndrome: randomized controlled trial of l-carnitine. Journal of Child Neurology. 1999;14:162–167.

33. Folstein S.E., Piven J. Etiology of autism: genetic influences. Pediatrics. 1991;87(5):767–773.

34. Fombonne E. Epidemiological trends in rates of autism. Molecular Psychiatry. 2002;7:S4–S6.

35. Frye R.E., Huffman L.C., Elliott G.R. Tetrahydrobiopterin as a novel therapeutic intervention for autism. Neurotherapeutics. 2010;7(3):214–249.

36. Geier D.A., Kern J.K., Davis G., King P.G., Adams J.B., Young J.L., Geier M.R. A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Medical Science Monitoring. 2011;17(6):15–23.

37. Glessner J.T., Wang K., Cai G., Korvatska O., Kim C.E. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009;459:569–573.

38. Kalra E.K. Nutraceutical – definition and introduction. AAPS Pharmaceutical Science. 2003;5(3):25–26.

39. Kidd P.M. Autism, an extreme challenge to integrative medicine. Part 2: Medical management. Alternative Medicine Reviews. 2002;7(6):472–499.

40. Kinney D.K., Miller A.M., Crowley D.J., Huang E., Gerber E. Autism prevalence following prenatal exposure to hurricanes and tropical storms in Louisiana. Journal of Autism and Developmental Disorders. 2008;38:481–488.

41. Knivsberg A.M., Reichelt K.L., Nodland M. Reports on dietary intervention in autistic disorders. Nutrition and Neuroscience. 2001;4(1):25–37.

42. Knivsberg A.M., Reichelt K.L., Hoien T., Nodland M. A randomised, controlled study of dietary intervention in autistic syndromes. Nutritional Neuroscience. 2002;5(4):251–261.

43. Kubota T., Miyake K., Hirasawa T. Epigenetic understanding of gene-environment interactions in psychiatric disorders: a new concept of clinical genetics. Clinical Epigenetics. 2012;4(1)

44. Levy S.E., Hyman S.L. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America. 2008;17(4):803–810.

45. Liu J., Nyholt D.R., Magnussen P., Parano E., Pavone P. A genomewide screen for autism susceptibility loci. American Journal of Human Genetics. 2001;69:327–340.

46. Lucarelli S., Frediani T., Zingani A., Ferruzzi A., Giardini O., Quintieri F. Food and infantile autism. Panminerva Medica. 1995;37(3):137–141.

47. Meaney M.J., Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues in Clinical Neuroscience. 2005;7(2):103–123.

48. Mehl-Madrona L., Leung B., Kennedy C., Paul S., Kaplan B.J. Micronutirent versus standard medication management in autism: a naturalistic case-control study. Journal of Child and Adolescent Psychopharmacology. 2010;20(2):95–103.

49. Morris C.R., Agin M.C. Syndrome of allergy, apraxia, and malabsorption: characterization of a neurodevelopmental phenotype that responds to omega 3 and vitamin E supplementation. Alternative Therapies in Health and Medicine. 2009;15(4):34–43.

50. Mostafa, A., 2011. Addressing autism in the Arab World. Nature Middle East <http://www.nature.com/nmiddleeast/2011/012345/full/nmiddleeast.2011.147.html>.

51. Muhle R., Trentacoste S.V., Rapin I. The genetics of autism. Pediatrics. 2004;113(5):472–486.

52. Mulloy A., Lang R., O’Reilly M., Sigafoos J., Giulio L., Rispoli M. Gluten-free and casein-free diets in the treatment of autism spectrum disorders: a systematic review. Research in Autism Spectrum Disorders. 2010;4:328–339.

53. Naruse H., Hayashi T., Takesada M., Nakane A., Yamazaki K., Noguchi T., Watanabe Y., Hayashi O. Therapeutic effect of tetrahydrobiopterin in infantile autism. Proceedings of the Japan Academy. 1987;63:231–233.

54. Naurse H., Hayashi T., Takesada M., Nakane A., Yamazaki K. Metabolic changes in aromatic amino acids and monoamines in infantile autism and development of new treatment related to the finding. No To Hattatsu (Brain and Development) 1989;21(2):181–189.

55. Pandey M., Verma R.K., Saraf S.A. Nutraceuticals: new era of medicine and health. Asian Journal of Pharmaceutical and Clinical Research. 2010;3(1):11–20.

56. Parker-Athill E., Luo D., Bailey A., Giunta B., Tian J., Shytle R.D., Murphy T., Legradi G., Tan J. Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autism. Journal of Neuroimmunology. 2009;217:20–27.

57. Parracho H.M.R.T., Gibson G.R., Knott F., Bosscher D., Kleerebezem M., McCartney A.L. A double-blind, placebo-controlled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorders. International Journal of Probiotics and Prebiotics. 2010;5(2):69–74.

58. Patel K., Curtis L.T. A comprehensive approach to treating autism and attention deficit hyperactivity disorder: a prepilot study. Journal of Alternative Complementary Medicine. 2007;13:1091–1097.

59. Payne S., Gibson G., Wynne A., Hudspith B., Brostoff J., Tuohy K. In vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and Lactobacillus plantarum LPK. Current Issues in Intestinal Microbiology. 2003;4(1):1–8.

60. Pennesi C.M., Klein L.C. Effectiveness of the gluten-free, casein-free diet for children diagnosed with autism spectrum disorder: based on parental report. Nutrition and Neuroscience. 2012;15(2):85–91.

61. Ploeger A., Galis F. Evolutionary approaches to autism – an overview and integration. MJM. 2011;13(2):38–43.

62. Rapin I. The autistic spectrum disorders. New England Journal of Medicine. 2002;347(5):302–304.

63. Richardson A.J. Long-chained polyunsaturated fatty acids in childhood developmental and psychiatric disorders. Lipids. 2004;39:1215–1222.

64. Roman G.C. Autism: transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and to other environmental antithyroid agents. Journal of Neurological Sciences. 2007;262(1–2):15–26.

65. Rutter M., Moffitt T.E., Caspi A. Gene-environment interplay and psychopathology: multiple varieties but real effects. Journal of Child Psychology, Psychiatry and Allied Disciplines. 2006;47(3–4):226–261.

66. Sakai Y., Shaw C.A., Dawson B.C., Dugas D.V., Mohtaseb Z., Hill D.E., Zoghbi Y. Protein interactome reveals converging molecular pathways among autism disorders. Science Translational Medicine. 2011;3(86):86ra49.

67. Schmidt R.J., Hansen Rl, Hartiala J., Allayee H., Schmidt L.C., Tancredi D.J., Tassone F., Hertz-Picciotto I. Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology. 2011;22:476–485.

68. Shattock P., Whiteley P. Autism Research Unit, University of Sunderland; Sunderland, UK: 2000. (The Sunderland Protocol: A Logical Sequencing of Biomedical Interventions for the Treatment of Autism and Related Disorders).

69. Sweeten T.L., Bowyer S.L., Posey D.J., Halberstadt C.M., McDougle C.J. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics. 2003;112:420.

70. Tani Y., Fernell E., Watanabe Y., Kanai T., Langstrom B. Decrease in 6R-5,6,7,8-tetrahydrobiopterin content in cerebrospinal fluid of autistic patients. Neuroscience Letters. 1994;181:169–172.

71. Theoharides T.C., Zhang B. Neuroinflammation, blood brain barrier, seizures and autism. Journal of Neuroinflammation. 2011;8:168.

72. Theoharides T.C., Asadi S., Panagiotidou S. A case series of a luteolin formulation (neuroprotek&#63194) in children with autism spectrum disorders. International Journal of Immunopathology Pharmacology. 2012;25(2):317–323.

73. Tonge B., Brereton A. Autism spectrum disorder. Australian Family Physician. 2011;40(9):672–677.

74. Vancassel S., Durand G., Barthelemy C., Lejeune B., Martineau J., Guilloteau D., Andres C., Chalon S. Plasma fatty acid levels in autisitc children. Prostaglandins, Leukotrines and Essential Fatty Acids. 2001;65(1):1–7.

75. Vojdani A., O’Bryan T., Green J.A., Mccandless J., Woeller K.N., Vojdani E., Nourian A.A., Cooper E.L. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutrition Neuroscience. 2004;7(3):151–161.

76. Wilczynski-Kwaitek A., Singh R.B., De Meester F. Nutrition and behavior: the role of ω3 fatty acids. The Open Nutraceutical Journal. 2009;2:1–10.

77. World Health Organization . WHO; Geneva: 1992. (The ICD-10 Classification of Mental and Behavioral Disorders (ICD-10)).

Learn More